Evidence map›Paper›PMID 23463944›Full record

ArticleACS chemical biology2013

A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.

Aurélien Godinat, Hyo Min Park, Stephen C Miller, Ke Cheng, Douglas Hanahan, Laura E Sanman, Matthew Bogyo, Allen Yu, Gennady F Nikitin, Andreas Stahl and 1 more

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. In vivo bioluminescence imaging of labile iron accumulation in a murine model ofProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Article
  12. In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  13. Economical and scalable synthesis of 6-amino-2-cyanobenzothiazole.Beilstein journal of organic chemistry · 2016
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Aurélien GodinatInstitute of Chemical Sciences and Engineering, Swiss Federal Institute of Technology of Lausanne, LCBIM, CH-1015 Lausanne, Switzerland.
Hyo Min Park
Stephen C Miller
Ke Cheng
Douglas Hanahan
Laura E Sanman
Matthew Bogyo
Allen Yu
Gennady F Nikitin
Andreas Stahl
Elena A Dubikovskaya
École Polytechnique Fédérale de Lausanne · CHUniversity of California, Berkeley · USUniversity of Massachusetts Chan Medical School · US

Funding

Small Molecule Imaging of Protease ActivityR01EB005011 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2005 to 2013
$3.0M
Enhanced synthetic luciferin substrates for firefly luciferaseR01EB013270 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MILLER, STEPHEN C. · 2011 to 2020
$2.9M
Molecular Physiology of Liver Fatty Acid TransportersR01DK066336 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI STAHL, ANDREAS · 2004 to 2013
$2.7M
DEPENDENCE OF THERMOGENESIS AND BROWN ADIPOSE TISSUE FUNCTION ON FATP1 AND CD36R01DK089202 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI STAHL, ANDREAS · 2011 to 2015
$1.9M
NIBIB NIH HHS R01 EB005011NIBIB NIH HHS R01 EB013270NIBIB NIH HHS R01EB013270NIBIB NIH HHS R01EB05011NIDDK NIH HHS R01 DK066336NIDDK NIH HHS R01DK066336-08NIDDK NIH HHS R01 DK089202NIDDK NIH HHS R01DK089202-01A1
6 · The paper itself

Abstract

The discovery of biocompatible reactions had a tremendous impact on chemical biology, allowing the study of numerous biological processes directly in complex systems. However, despite the fact that multiple biocompatible reactions have been developed in the past decade, very few work well in living mice. Here we report that D-cysteine and 2-cyanobenzothiazoles can selectively react with each other in vivo to generate a luciferin substrate for firefly luciferase. The success of this "split luciferin" ligation reaction has important implications for both in vivo imaging and biocompatible labeling strategies. First, the production of a luciferin substrate can be visualized in a live mouse by bioluminescence imaging (BLI) and furthermore allows interrogation of targeted tissues using a "caged" luciferin approach. We therefore applied this reaction to the real-time noninvasive imaging of apoptosis associated with caspase 3/7. Caspase-dependent release of free D-cysteine from the caspase 3/7 peptide substrate Asp-Glu-Val-Asp-D-Cys (DEVD-(D-Cys)) allowed selective reaction with 6-amino-2-cyanobenzothiazole (NH(2)-CBT) in vivo to form 6-amino-D-luciferin with subsequent light emission from luciferase. Importantly, this strategy was found to be superior to the commercially available DEVD-aminoluciferin substrate for imaging of caspase 3/7 activity. Moreover, the split luciferin approach enables the modular construction of bioluminogenic sensors, where either or both reaction partners could be caged to report on multiple biological events. Lastly, the luciferin ligation reaction is 3 orders of magnitude faster than Staudinger ligation, suggesting further applications for both bioluminescence and specific molecular targeting in vivo.

Indexed as

AnimalsApoptosisBenzothiazolesCaspase 3Caspase 7Cell Line, TumorCysteineFemaleFirefly LuciferinHumansKineticsLuciferases, FireflyLuminescent AgentsLuminescent MeasurementsMiceMice, Transgenic2-cyanobenzothiazoleaspartyl-glutamyl-valyl-aspartyl-aminoluciferinBenzothiazolesCaspase 3Caspase 7CysteineD-luciferinFirefly LuciferinLuciferases, FireflyLuminescent AgentsNitrilesOligopeptidesPeptide HydrolasesThrombin

Identifiers

PMID23463944
PMCPMC3836283
OpenAlexW1987572650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.